ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,422Medicare Part D Prescriptions Filled, Including Refills

Rank: 54 out of 336

$945K Total Retail Price of All Prescriptions

Rank: 47 out of 336

953 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 953 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

9% of this provider’s 953 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 12,848 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
SIMVASTATIN 815 698 1 5
LEVOTHYROXINE SODIUM 787 609 2 7
AMLODIPINE BESYLATE 759 620 3 1
OMEPRAZOLE 495 398 4 3
CARVEDILOL 442 373 5 13
FUROSEMIDE 407 313 6 4
ATORVASTATIN CALCIUM 376 237 7 14
LISINOPRIL 356 277 8 6
HYDROCHLOROTHIAZIDE 324 270 9 12
FENOFIBRATE 316 254 10 72
WARFARIN SODIUM 297 231 11 17
METFORMIN HCL 288 173 12 8
HYDROCODONE-ACETAMINOPHEN 229 164 S3 13 2
PRAVASTATIN SODIUM 228 162 14 10
PROAIR HFA 222 124 15 77
SPIRIVA 220 141 16 88
POTASSIUM CHLORIDE 219 179 17 9
CITALOPRAM HBR 219 148 17 21
ATENOLOL 213 161 19 26
GABAPENTIN 212 152 20 11
TRIAMTERENE-HCTZ 201 163 21 35
ZOLPIDEM TARTRATE 199 142 22 18
NEXIUM 194 124 23 24
AZITHROMYCIN 183 114 24 58
TRAMADOL HCL 182 139 25 20
SERTRALINE HCL 177 140 26 33
CRESTOR 160 110 27 25
DONEPEZIL HCL 155 146 28 27
CLOPIDOGREL 148 120 29 28
METOPROLOL TARTRATE 146 128 30 16
METHYLPREDNISOLONE 145 101 31 104
GLYBURIDE 134 93 R 32 76
LISINOPRIL-HYDROCHLOROTHIAZIDE 133 93 33 23
PANTOPRAZOLE SODIUM 131 96 34 40
MELOXICAM 124 104 35 19
ADVAIR DISKUS 124 71 35 82
LEVOFLOXACIN 121 82 37 93
CLONIDINE HCL 113 77 38 32
KLOR-CON M20 106 91 39 51
PLAVIX 100 82 40 37
CYCLOBENZAPRINE HCL 99 63 R 41 65
NIASPAN 98 70 42 139
ALLOPURINOL 96 91 43 30
WELCHOL 92 68 44 195
BENAZEPRIL HCL 90 71 45 59
METOPROLOL SUCCINATE 87 78 46 15
LOSARTAN POTASSIUM 84 63 47 22
RANITIDINE HCL 82 38 48 36
HYDRALAZINE HCL 81 72 49 53
ZETIA 81 56 49 74
AMOX TR-POTASSIUM CLAVULANATE 79 48 51 144
SYNTHROID 78 78 52 43
VENTOLIN HFA 78 55 52 130
CIPROFLOXACIN HCL 76 37 54 55
FLUTICASONE PROPIONATE 76 45 54 49
SYMBICORT 75 46 56 155
PEN NEEDLE 74 52 57 162
TRAZODONE HCL 73 43 58 46
SINGULAIR 71 57 59 85
BUSPIRONE HCL 71 40 59 113
FLUCONAZOLE 70 31 61 151
ROPINIROLE HCL 70 58 61 98
BUMETANIDE 69 47 63 116
CYMBALTA 68 51 64 52
FENTANYL 66 40 S2 65 120
PREDNISONE 66 52 65 48
CEPHALEXIN 65 57 67 109
LACTULOSE 63 42 68 143
VYTORIN 63 50 68 122
LOVAZA 62 19 70 157
ALENDRONATE SODIUM 61 60 71 54
PAROXETINE HCL 59 44 72 64
INSULIN SYRINGE 58 39 73 102
MONTELUKAST SODIUM 58 47 73 140
MECLIZINE HCL 58 52 73 96
LYRICA 55 16 76 70
GLIPIZIDE 55 49 76 71
TAMSULOSIN HCL 54 52 78 38
ESCITALOPRAM OXALATE 53 40 79 69
NAMENDA 53 53 79 39
FLUOXETINE HCL 52 34 81 81
KLOR-CON 10 52 50 81 75
GLIMEPIRIDE 51 35 83 29
OXYBUTYNIN CHLORIDE 50 41 84 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 10, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.